TipRanks on MSN
Crispr Therapeutics announces Phase 1 data for CTX310
CRISPR Therapeutics (CRSP) announced positive Phase 1 data from its ongoing clinical trial evaluating CTX310, an investigational, in vivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback